Literature DB >> 2415793

A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum.

P H Andersen, F C Grønvald, J A Jansen.   

Abstract

Methods for measuring 3H-SCH 23390 binding and dopamine (DA) stimulated adenylate cyclase (AC) were established in identical tissue preparations and under similar experimental conditions. Pharmacological characterization revealed that both assays involved interaction with the D1 receptor or closely associated sites. In order to investigate whether the binding sites for 3H-SCH 23390 and DA in fact are identical, the antagonistic effects of a variety of pharmacologically active compounds were examined. Surprisingly, the Ki-values obtained from Schild-plot analysis of the antagonism of DA-stimulated AC, were 80-240 times higher than the Ki-values obtained from competition curves of 3H-SCH 23390 binding. Since both assays were performed under identical conditions, the differences in Ki-values indicate the possibility of different binding sites for DA and 3H-SCH 23390 or, that DA and 3H-SCH 23390 label different states of the same receptor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415793     DOI: 10.1016/0024-3205(85)90028-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  22 in total

1.  Kinetics and pharmacology of the D1- and D2-like dopamine receptors in Japanese quail brain.

Authors:  Lubica Kubíková; Pavel Výboh; Lubor Kostál
Journal:  Cell Mol Neurobiol       Date:  2009-03-28       Impact factor: 5.046

2.  Characterization of the dopamine receptor mediating the hyperpolarization of cockroach salivary gland acinar cells in vitro.

Authors:  A M Evans; K L Green
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

3.  Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

Authors:  C A Altar; W C Boyar; A Wasley; S C Gerhardt; J M Liebman; P L Wood
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

4.  Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.

Authors:  J A Stamford; Z L Kruk; J Millar
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

5.  Modulation of inhibitory transmission by dopamine in rat basal forebrain nuclei: activation of presynaptic D1-like dopaminergic receptors.

Authors:  T Momiyama; J A Sim
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

6.  Sensitivity to apomorphine-induced yawning and hypothermia in rats eating standard or high-fat chow.

Authors:  Michelle G Baladi; Yvonne M Thomas; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2011-12-30       Impact factor: 4.530

7.  Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.

Authors:  C A Briggs; N J Pollock; D E Frail; C L Paxson; R F Rakowski; C H Kang; J W Kebabian
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

8.  Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.

Authors:  Y Hatta; S Hatta; T Saito
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 10.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.